Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?
The pharmaceutical company has had a torrid history. The new development could prove to be its redemption
At Searle, revenue growth is now about volumes, not just prices
The company has also managed to secure alternative input suppliers are disruption on trade with India
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Pharmaceuticals: how the locals are beating the multinationals
In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change
Afghan trade halt hits Pakistan’s $200 million pharma exports, medicine containers struck at Torkham, Chaman borders
PPMA warns over 50 pharma firms face losses as temperature-sensitive medicines risk expiry; industry urges govt to allow exports on humanitarian grounds
Senate panel alarmed as medicine prices jump 32% after price controls lifted
Health ministry reports some essential drugs have doubled in cost, prompting inquiry into deregulation impact; Pharmaceutical Manufacturers Association disputes the official figures
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
The mechanics behind the panadol shortage
Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on
Descon Oxychem takes a hit as imports flood the market
Some exporting customers are allowed to purchase foreign competitors’ products, causing Descon to lose market share
DRAP’s survey on drug price hikes irks pharmaceutical manufacturers
Third-party survey initiated in response to public outcry over rising medicine prices after deregulation of non-essential drugs; PPMA voices concerns over lack of industry stakeholder involvement
Searle is lagging the pharmaceutical sector. Its recovery might be just around the corner
The pharmaceutical company has had lackluster numbers in recent times. All that might be about to change
As Panadol prices stabilise, Haleon’s revenue growth slows
The boost from deregulated drug prices is stalling, causing Haleon to look at new product launches in nutraceuticals and export markets for growth
BF Bioscience, pharma company owned by Ferozsons and Argentinian Bago Group, got a stellar response to its IPO. What lies ahead?
The pharma company, which has been exporting to countries like Indonesia, Belarus and Ukraine, saw book building at Rs 77/share and oversubscription of 3.4 times.